Cargando…
Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study
BACKGROUND: Hepatitis C virus is the leading cause of liver cirrhosis and hepatocellular carcinoma in Japan. We aimed to examine the long-term (> 20 years) mortality and hepatocellular carcinoma rates and associated risk factors in 1412 Japanese patients with decompensated hepatitis C virus-relat...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066946/ https://www.ncbi.nlm.nih.gov/pubmed/33892649 http://dx.doi.org/10.1186/s12876-021-01770-0 |
_version_ | 1783682686753177600 |
---|---|
author | Fujiyama, Shunichiro Akuta, Norio Sezaki, Hitomi Kobayashi, Mariko Kawamura, Yusuke Hosaka, Tetsuya Kobayashi, Masahiro Saitoh, Satoshi Suzuki, Fumitaka Suzuki, Yoshiyuki Arase, Yasuji Ikeda, Kenji Kumada, Hiromitsu |
author_facet | Fujiyama, Shunichiro Akuta, Norio Sezaki, Hitomi Kobayashi, Mariko Kawamura, Yusuke Hosaka, Tetsuya Kobayashi, Masahiro Saitoh, Satoshi Suzuki, Fumitaka Suzuki, Yoshiyuki Arase, Yasuji Ikeda, Kenji Kumada, Hiromitsu |
author_sort | Fujiyama, Shunichiro |
collection | PubMed |
description | BACKGROUND: Hepatitis C virus is the leading cause of liver cirrhosis and hepatocellular carcinoma in Japan. We aimed to examine the long-term (> 20 years) mortality and hepatocellular carcinoma rates and associated risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis (Child–Pugh B or C). METHODS: Cumulative survival and hepatocellular carcinoma rates were determined using Kaplan–Meier analysis. Independent risk factors were identified by multivariate analysis. A two-tailed P-value of < 0.05 was considered significant. RESULTS: The patients were followed up for a median of 2 years (range 0.5–24.2 years). In total, 62.3%, 41.7%, 4.7%, and 68.3% of the patients had a history of hepatocellular carcinoma, ascites, hepatic encephalopathy, and esophageal varices, respectively. The 1-, 5-, 10-, and 20-year cumulative overall survival rates in the total cohort was 74.9%, 29.0%, 9.1%, and 1.4%, respectively. The 1-, 3-, 5-, and 10-year cumulative survival rates for patients without hepatocellular carcinoma were 93.1%, 54.4%, 18.2%, and 4.0%, respectively, and the corresponding cumulative post-decompensation hepatocellular carcinoma rates were 14.0%, 31.6%, 46.1%, and 66.2%, respectively. The independent risk factors for mortality were older age, Child–Pugh C cirrhosis, the presence of hepatocellular carcinoma, low estimated glomerular filtration rate, low serum sodium level, low platelet count, and high γ-glutamyl transferase and α-fetoprotein levels for all patients and older age, Child–Pugh C cirrhosis, and low estimated glomerular filtration rate for patients without hepatocellular carcinoma. Overall, 1035 patients (73.3%) died; the causes of death were liver failure with/without hepatocellular carcinoma, pneumonia, sepsis, cardiovascular disease, and non-hepatocellular carcinoma malignancies. The corresponding morality rates per person-year were 133.4, 59.9, 10.9, 10.6, 9.0, and 5.2, respectively. CONCLUSIONS: Among Japanese patients with decompensated hepatitis C virus-related cirrhosis, hepatocellular carcinoma is associated with poor prognosis. Our results highlight the importance of managing liver-related events, including hepatocellular carcinoma, in these patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-021-01770-0. |
format | Online Article Text |
id | pubmed-8066946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80669462021-04-26 Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study Fujiyama, Shunichiro Akuta, Norio Sezaki, Hitomi Kobayashi, Mariko Kawamura, Yusuke Hosaka, Tetsuya Kobayashi, Masahiro Saitoh, Satoshi Suzuki, Fumitaka Suzuki, Yoshiyuki Arase, Yasuji Ikeda, Kenji Kumada, Hiromitsu BMC Gastroenterol Research BACKGROUND: Hepatitis C virus is the leading cause of liver cirrhosis and hepatocellular carcinoma in Japan. We aimed to examine the long-term (> 20 years) mortality and hepatocellular carcinoma rates and associated risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis (Child–Pugh B or C). METHODS: Cumulative survival and hepatocellular carcinoma rates were determined using Kaplan–Meier analysis. Independent risk factors were identified by multivariate analysis. A two-tailed P-value of < 0.05 was considered significant. RESULTS: The patients were followed up for a median of 2 years (range 0.5–24.2 years). In total, 62.3%, 41.7%, 4.7%, and 68.3% of the patients had a history of hepatocellular carcinoma, ascites, hepatic encephalopathy, and esophageal varices, respectively. The 1-, 5-, 10-, and 20-year cumulative overall survival rates in the total cohort was 74.9%, 29.0%, 9.1%, and 1.4%, respectively. The 1-, 3-, 5-, and 10-year cumulative survival rates for patients without hepatocellular carcinoma were 93.1%, 54.4%, 18.2%, and 4.0%, respectively, and the corresponding cumulative post-decompensation hepatocellular carcinoma rates were 14.0%, 31.6%, 46.1%, and 66.2%, respectively. The independent risk factors for mortality were older age, Child–Pugh C cirrhosis, the presence of hepatocellular carcinoma, low estimated glomerular filtration rate, low serum sodium level, low platelet count, and high γ-glutamyl transferase and α-fetoprotein levels for all patients and older age, Child–Pugh C cirrhosis, and low estimated glomerular filtration rate for patients without hepatocellular carcinoma. Overall, 1035 patients (73.3%) died; the causes of death were liver failure with/without hepatocellular carcinoma, pneumonia, sepsis, cardiovascular disease, and non-hepatocellular carcinoma malignancies. The corresponding morality rates per person-year were 133.4, 59.9, 10.9, 10.6, 9.0, and 5.2, respectively. CONCLUSIONS: Among Japanese patients with decompensated hepatitis C virus-related cirrhosis, hepatocellular carcinoma is associated with poor prognosis. Our results highlight the importance of managing liver-related events, including hepatocellular carcinoma, in these patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-021-01770-0. BioMed Central 2021-04-23 /pmc/articles/PMC8066946/ /pubmed/33892649 http://dx.doi.org/10.1186/s12876-021-01770-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Fujiyama, Shunichiro Akuta, Norio Sezaki, Hitomi Kobayashi, Mariko Kawamura, Yusuke Hosaka, Tetsuya Kobayashi, Masahiro Saitoh, Satoshi Suzuki, Fumitaka Suzuki, Yoshiyuki Arase, Yasuji Ikeda, Kenji Kumada, Hiromitsu Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study |
title | Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study |
title_full | Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study |
title_fullStr | Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study |
title_full_unstemmed | Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study |
title_short | Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study |
title_sort | mortality rates and risk factors in 1412 japanese patients with decompensated hepatitis c virus-related cirrhosis: a retrospective long-term cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066946/ https://www.ncbi.nlm.nih.gov/pubmed/33892649 http://dx.doi.org/10.1186/s12876-021-01770-0 |
work_keys_str_mv | AT fujiyamashunichiro mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy AT akutanorio mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy AT sezakihitomi mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy AT kobayashimariko mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy AT kawamurayusuke mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy AT hosakatetsuya mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy AT kobayashimasahiro mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy AT saitohsatoshi mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy AT suzukifumitaka mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy AT suzukiyoshiyuki mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy AT araseyasuji mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy AT ikedakenji mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy AT kumadahiromitsu mortalityratesandriskfactorsin1412japanesepatientswithdecompensatedhepatitiscvirusrelatedcirrhosisaretrospectivelongtermcohortstudy |